Severely impaired humoral response against SARS-CoV-2 variants of concern following two doses of BNT162b2 vaccine in patients with systemic lupus erythematosus (SLE).

Arthur MageauValentine Marie FerréTiphaine GoulenokCharlotte CharpentierNicole DeloryChrystel FrancoisNadhira Houhou-FidouhThomas PapoDiane DescampsKarim Sacre

Published in: Annals of the rheumatic diseases (2022)

Keyphrases

sars cov
systemic lupus erythematosus
immune response
respiratory syndrome coronavirus
copy number
disease activity
rheumatoid arthritis
coronavirus disease